FDA Warning Letter — Doubletree Suites
The FDA took a Warning Letter action against Doubletree Suites on Nov 3, 2016 (Mount Laurel, NJ). The action was issued by CTP and concerns tobacco products.
Action details
- Facility
- Doubletree Suites
- Date
- Nov 3, 2016
- Fiscal Year
- 2017
- Product Type
- Tobacco
- Center
- CTP
- Location
- Mount Laurel, NJ (United States)